| |
 |
|
Class Information
Number: 514/192
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > 1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.)
Description:
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7595310 |
Glucuronate salt of a piperazine compound |
Sep. 29, 2009 |
| 7498312 |
Compositions containing piperacillin and tazobactam useful for injection |
Mar. 3, 2009 |
| 7307062 |
Method for treating a mental disorder |
Dec. 11, 2007 |
| 7241741 |
Methods and compositions for the treatment of asthma and related disorders |
Jul. 10, 2007 |
| 7101572 |
Taste masked aqueous liquid pharmaceutical composition |
Sep. 5, 2006 |
| 7094431 |
Method of healing skin wounds in mammals and a composition therefor |
Aug. 22, 2006 |
| 7094397 |
Methods and reagents for the treatment of multiple sclerosis |
Aug. 22, 2006 |
| 7067500 |
Betaines as adjuvants to susceptibility testing and antimicrobial therapy |
Jun. 27, 2006 |
| 6949519 |
Macrolide solvates |
Sep. 27, 2005 |
| 6900184 |
Compositions containing pipercillin and tazobactam useful for injection |
May. 31, 2005 |
| 6890526 |
Methods and reagents for the treatment of multiple sclerosis |
May. 10, 2005 |
| 6884784 |
Diagnosis and management of infection caused by chlamydia |
Apr. 26, 2005 |
| 6806256 |
Taste masked liquid pharmaceutical compositions |
Oct. 19, 2004 |
| 6756369 |
Diagnosis and management of infection caused by Chlamydia |
Jun. 29, 2004 |
| 6743440 |
Polycyclic quinone and ionophore composition for the synergistic reduction of methane formation in ruminant animals |
Jun. 1, 2004 |
| 6706290 |
Methods for eradication of nanobacteria |
Mar. 16, 2004 |
| 6689756 |
Treatment of neurological disease |
Feb. 10, 2004 |
| 6664239 |
Diagnosis and management of infection caused by Chlamydia |
Dec. 16, 2003 |
| 6630135 |
Use of sustained release antibiotic compositions in ophthalmic surgical procedures |
Oct. 7, 2003 |
| 6627625 |
Treatment of behavioral disorders with .beta.-lactam compounds |
Sep. 30, 2003 |
| 6610652 |
Microdose therapy |
Aug. 26, 2003 |
| 6579854 |
Diagnosis and management of infection caused by chlamydia |
Jun. 17, 2003 |
| 6576625 |
Targeted vesicular constructs for cytoprotection and treatment of H. pylori infections |
Jun. 10, 2003 |
| 6565882 |
Antibiotic composition with inhibitor |
May. 20, 2003 |
| 6544991 |
Compositions and methods for treating bacterial infections |
Apr. 8, 2003 |
| 6518252 |
Method of treating aquatic animals with an antimicrobial agent and chelating agent |
Feb. 11, 2003 |
| 6512004 |
Promoters of neural regeneration |
Jan. 28, 2003 |
| 6495539 |
B-lactam-like chaperone inhibitors |
Dec. 17, 2002 |
| 6489317 |
Method for eradication of Helicobacter pylori |
Dec. 3, 2002 |
| 6475522 |
Synthetic polymer compositions containing antibiotics as antidegradants |
Nov. 5, 2002 |
| 6461607 |
Probiotic, lactic acid-producing bacteria and uses thereof |
Oct. 8, 2002 |
| 6436398 |
2 .beta.-substituted-6-alkylidene penicillanic acid derivatives as .beta.-lactamase inhibitors |
Aug. 20, 2002 |
| 6429191 |
Treatment of hearing impairments |
Aug. 6, 2002 |
| 6426342 |
Use of .beta.-lactamase inhibitors as neuroprotectants |
Jul. 30, 2002 |
| 6423683 |
Microdose therapy |
Jul. 23, 2002 |
| 6406880 |
Betaines as adjuvants to susceptibility testing and antimicrobial therapy |
Jun. 18, 2002 |
| 6380181 |
Synthetic catechol derivatives, method for production and use thereof |
Apr. 30, 2002 |
| 6365635 |
Antibacterial composition for topical administration containing antibiotic |
Apr. 2, 2002 |
| 6335358 |
Lactacystin analogs |
Jan. 1, 2002 |
| 6333305 |
Antibiotic TKR2999, process for the preparation thereof and microbe |
Dec. 25, 2001 |
| 6326387 |
Methods and compositions for stimulating neurite growth |
Dec. 4, 2001 |
| 6319904 |
Formulation comprising antibacterial substance and antiulcer substance |
Nov. 20, 2001 |
| 6294526 |
Use of flavone derivatives for induction of .beta.-lactam-sensitivity of MRSA |
Sep. 25, 2001 |
| 6284744 |
Peritoneal induced medicaments |
Sep. 4, 2001 |
| 6277829 |
Process for preparing of aqueous formulation for opthalmic use |
Aug. 21, 2001 |
| 6271222 |
Penem antibacterial compounds, compositions and methods of treatment |
Aug. 7, 2001 |
| 6268352 |
Promoters of neural regeneration |
Jul. 31, 2001 |
| 6248718 |
Lesion-directed dry dosage forms of antibacterial agents for the treatment of acute mucosal infections of the oral cavity |
Jun. 19, 2001 |
| 6232305 |
Substituted amino bicyclic-.beta.-lactam penam and cepham derivatives as cysteine protease inhibitors |
May. 15, 2001 |
| 6225282 |
Treatment of hearing impairments |
May. 1, 2001 |
|
|
|
